Gerresheimer AG (ETR:GXI) has been given a €75.00 ($88.24) price target by stock analysts at Berenberg Bank in a note issued to investors on Wednesday. The brokerage currently has a “buy” rating on the stock.
A number of other brokerages have also recently weighed in on GXI. Deutsche Bank AG set a €62.00 ($72.94) price target on shares of Gerresheimer AG and gave the stock a “neutral” rating in a research note on Tuesday, September 5th. J P Morgan Chase & Co set a €99.40 ($116.94) price target on shares of Gerresheimer AG and gave the stock a “buy” rating in a research note on Thursday, August 31st. Independent Research GmbH set a €78.00 ($91.76) price target on shares of Gerresheimer AG and gave the stock a “neutral” rating in a research note on Wednesday, July 19th. DZ Bank AG reiterated a “buy” rating on shares of Gerresheimer AG in a research note on Monday, July 17th. Finally, Hauck & Aufhaeuser set a €80.00 ($94.12) price target on shares of Gerresheimer AG and gave the stock a “neutral” rating in a research note on Friday, July 14th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and five have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of €72.94 ($85.81).
Gerresheimer AG (GXI) opened at 65.99 on Wednesday. The company’s 50 day moving average is €65.42 and its 200 day moving average is €70.49. The stock has a market cap of €2.07 billion and a PE ratio of 18.28. Gerresheimer AG has a one year low of €59.97 and a one year high of €79.47.
About Gerresheimer AG
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.